Company: AFT Pharmaceuticals Limited
Last Updated: Fri 24th Jul17:30Last Updated: 17:30
AFT Pharmaceuticals Ltd Ordinary Shares(AFT)
$4.2700NZD+$0.2700 +6.75%
| Issued By: | AFT Pharmaceuticals Limited |
|---|---|
| ISIN: | NZAFTE0001S4 |
| Type: | Ordinary Shares |
| 52 Week Change: | No Change |
Activity
| Trading Status | Trading |
|---|---|
| Trades | 99 |
| Value | $395,998.03 |
| Volume | 95,031 |
| Capitalisation (000s) | $447,815 |
Performance
| Open | $4.0000 |
|---|---|
| High | $4.2800 |
| Low | $4.0000 |
| High Bid | $4.2600 |
| Low Offer | $4.2700 |
Fundamentals
| P/E | 30.392 |
|---|---|
| EPS | $0.141 |
| NTA | $0.430 |
| Gross Div Yield | 0.868% |
| Securities Issued | 104,874,660 |
Dividends
Subscribe to our Corporate Actions product for a full list of dividends.
1.600c
1.800c
0.972c
0.441c
2.500c
Dividend AmountSupplementary AmountDividend Imputation
upcoming Dividends
There are no upcoming dividendshistorical Dividends
| Ex Dividend | Currency | Amount |
|---|---|---|
| 18 Jun 2026 | NZD | 2.500c |
| 18 Jun 2025 | NZD | 1.800c |
| 19 Jun 2024 | NZD | 1.600c |
About Company
Company Executives
| David Flacks | Chairman |
|---|---|
| Hartley Atkinson | Chief Executive Officer, Executive Director |
| Stuart Houliston | Chief Financial Officer |
| Allison Yorston | Independent Director |
| Marree Atkinson | Executive Director |
| Andrew Lane | Director |
Company Board
| Ted Witek | Independent Non-Executive Director |
|---|
Company Summary
| First Listed | 21st Dec 2015 |
|---|---|
| Primary Listing Venue | NZ |
| Solicitor | Harmos Horton Lusk Limited |
| Auditor | Deloitte |
| Share Registry | Computershare Investor Services Limited |
| End of Financial Year | March |